-
1
-
-
79751531393
-
Heart disease and stroke statistics - 2011 update: A report from the American Heart Association
-
American Heart Association Statistics Committee and Stroke Statistics Subcommittee et al. 21160056 10.1161/CIR.0b013e3182009701
-
Roger VL, Go AS, Lloyd-Jones DM, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18-209.
-
(2011)
Circulation.
, vol.123
, Issue.4
-
-
Roger, V.L.1
Go, A.S.2
Lloyd-Jones, D.M.3
-
2
-
-
0035804846
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
-
Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators et al. 11277825 10.1001/jama.285.13.1711 1:CAS:528:DC%2BD3MXivFGnurc%3D
-
Schwartz GG, Olsson AG, Ezekowitz MD, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285(13):1711-8.
-
(2001)
JAMA
, vol.285
, Issue.13
, pp. 1711-1718
-
-
Schwartz, G.G.1
Olsson, A.G.2
Ezekowitz, M.D.3
-
4
-
-
70349675844
-
Acute coronary syndromes: Morbidity, mortality, and pharmacoeconomic burden
-
19355807
-
Kolansky DM. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care. 2009;15(2 Suppl):S36-41.
-
(2009)
Am J Manag Care.
, vol.15
, Issue.SUPPL. 2
-
-
Kolansky, D.M.1
-
5
-
-
11144355354
-
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
-
15007110 10.1056/NEJMoa040583 1:CAS:528:DC%2BD2cXjtVeqtr8%3D
-
Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-504.
-
(2004)
N Engl J Med.
, vol.350
, pp. 1495-1504
-
-
Cannon, C.P.1
Braunwald, E.2
McCabe, C.H.3
-
6
-
-
38349171836
-
Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: Results from the PROVE IT-TIMI 22 study
-
18222355 10.1016/j.jacc.2007.10.017 1:CAS:528:DC%2BD1cXhtV2ntL8%3D
-
Iakoubova OA, Sabatine MS, Rowland CM, et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. J Am Coll Cardiol. 2008;51:449-55.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 449-455
-
-
Iakoubova, O.A.1
Sabatine, M.S.2
Rowland, C.M.3
-
7
-
-
38349118892
-
Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary disease in 2 prospective trials: The CARE and WOSCOPS trials
-
18222353 10.1016/j.jacc.2007.05.057 1:CAS:528:DC%2BD1cXhtV2nt7c%3D
-
Iakoubova OA, Tong CH, Rowland CM, et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol. 2008;51:435-43.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 435-443
-
-
Iakoubova, O.A.1
Tong, C.H.2
Rowland, C.M.3
-
8
-
-
4544243333
-
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial
-
15337732 10.1001/jama.292.11.1307
-
de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA. 2004;292(11):1307-16.
-
(2004)
JAMA
, vol.292
, Issue.11
, pp. 1307-1316
-
-
De Lemos, J.A.1
Blazing, M.A.2
Wiviott, S.D.3
-
9
-
-
77956947971
-
KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy
-
20854963 10.1016/j.amjcard.2010.05.033 1:CAS:528:DC%2BC3cXhtFOntbjF
-
Li Y, Iakoubova OA, Shiffman D, et al. KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy. Am J Cardiol. 2010;106(7):994-8.
-
(2010)
Am J Cardiol.
, vol.106
, Issue.7
, pp. 994-998
-
-
Li, Y.1
Iakoubova, O.A.2
Shiffman, D.3
-
10
-
-
75249095390
-
Adherence and chemoprevention in major cardiovascular disease: A simulation study of the benefits of additional use of statins
-
20056964 10.1136/jech.2009.091033 1:STN:280:DC%2BC3c%2Fht1KltA%3D%3D
-
Shroufi A, Powles JW. Adherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statins. J Epidemiol Community Health. 2010;64(2):109-13.
-
(2010)
J Epidemiol Community Health.
, vol.64
, Issue.2
, pp. 109-113
-
-
Shroufi, A.1
Powles, J.W.2
-
11
-
-
67649195258
-
Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain and Germany, based on the Treating to New Targets study
-
18800232 10.1007/s10198-008-0126-1
-
Taylor DCA, Pandya A, Thompson D, et al. Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain and Germany, based on the Treating to New Targets study. Eur J Health Econ. 2009;10:255-65.
-
(2009)
Eur J Health Econ
, vol.10
, pp. 255-265
-
-
Taylor, D.C.A.1
Pandya, A.2
Thompson, D.3
-
12
-
-
0034044352
-
The natural history of prevalent ischaemic heart disease in middle-aged men
-
10843823 10.1053/euhj.1999.1866 1:STN:280:DC%2BD3czpsFWlsw%3D%3D
-
Lampe FC, Whincup PH, Wannamethee SG, et al. The natural history of prevalent ischaemic heart disease in middle-aged men. Eur Heart J. 2000;21(13):1052-62.
-
(2000)
Eur Heart J.
, vol.21
, Issue.13
, pp. 1052-1062
-
-
Lampe, F.C.1
Whincup, P.H.2
Wannamethee, S.G.3
-
13
-
-
80051499508
-
-
Celera
-
Data on file. Celera, 2011.
-
(2011)
Data on File
-
-
-
14
-
-
84878819029
-
-
Eden Prairie (MN): Optum Accessed 2 Jun 2012
-
DrugReimbursement.com (online database). Eden Prairie (MN): Optum; 2012. http://www.drugreimbursement.com/drc/. Accessed 2 Jun 2012.
-
(2012)
DrugReimbursement.com (Online Database)
-
-
-
15
-
-
80054102146
-
-
Montvale (NJ): Thomson PDR
-
Drug topics red book 2010. Montvale (NJ): Thomson PDR; 2010.
-
(2010)
Drug Topics Red Book 2010
-
-
-
16
-
-
79960145526
-
Cost estimation of cardiovascular disease events in the US
-
21585226 10.2165/11584620-000000000-00000
-
O'Sullivan AK, Rubin J, Nyambose J, et al. Cost estimation of cardiovascular disease events in the US. Pharmacoeconomics. 2011;29(8):693-704.
-
(2011)
Pharmacoeconomics.
, vol.29
, Issue.8
, pp. 693-704
-
-
O'Sullivan, A.K.1
Rubin, J.2
Nyambose, J.3
-
17
-
-
79955601866
-
United States life tables 2006
-
Arias E. United States life tables 2006. Natl Vital Stat Rep. 2010;58(21):1-40.
-
(2010)
Natl Vital Stat Rep.
, vol.58
, Issue.21
, pp. 1-40
-
-
Arias, E.1
-
18
-
-
22244440228
-
A national catalog of preference-based scores for chronic conditions in the United States
-
15970790 10.1097/01.mlr.0000172050.67085.4f
-
Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43:736-49.
-
(2005)
Med Care.
, vol.43
, pp. 736-749
-
-
Sullivan, P.W.1
Lawrence, W.F.2
Ghushchyan, V.3
-
19
-
-
33644556119
-
Visualizing coronary calcium is associated with improvements in adherence to statin therapy
-
16051253 10.1016/j.atherosclerosis.2005.06.018 1:CAS:528: DC%2BD28XitVKgt78%3D
-
Kalia NK, Miller LG, Nasir K, et al. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185(2):394-9.
-
(2006)
Atherosclerosis.
, vol.185
, Issue.2
, pp. 394-399
-
-
Kalia, N.K.1
Miller, L.G.2
Nasir, K.3
-
20
-
-
84872605674
-
Patient knowledge of pharmacogenetic information improves adherence to statin therapy: Results of the additional KIF6 risk offers better adherence to statins (AKROBATS) trial
-
10.1016/S0735-1097(12)61849-X
-
Charland SL, Agatep BC, Epstein RS, et al. Patient knowledge of pharmacogenetic information improves adherence to statin therapy: results of the additional KIF6 risk offers better adherence to statins (AKROBATS) trial. J Am Coll Cardiol. 2012;59(13):E1848.
-
(2012)
J Am Coll Cardiol
, vol.59
, Issue.13
, pp. 1848
-
-
Charland, S.L.1
Agatep, B.C.2
Epstein, R.S.3
-
21
-
-
70450221024
-
Much cheaper, almost as good: Decrementally cost-effective medical innovation
-
19884627 10.7326/0003-4819-151-9-200911030-00011
-
Nelson AL, Cohen JT, Greenberg D, et al. Much cheaper, almost as good: decrementally cost-effective medical innovation. Ann Intern Med. 2009;151:662-7.
-
(2009)
Ann Intern Med.
, vol.151
, pp. 662-667
-
-
Nelson, A.L.1
Cohen, J.T.2
Greenberg, D.3
-
22
-
-
14644403669
-
Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia
-
15735194 10.2337/diacare.28.3.595 1:CAS:528:DC%2BD2MXivVaisrs%3D
-
Parris ES, Lawrence DB, Mohn LA, et al. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care. 2005;28(3):595-9.
-
(2005)
Diabetes Care.
, vol.28
, Issue.3
, pp. 595-599
-
-
Parris, E.S.1
Lawrence, D.B.2
Mohn, L.A.3
-
23
-
-
78751621806
-
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. (J Am Coll Cardiol. 2010 Nov 2, 56(19), pp. 1552-63. Erratum in)
-
10.1016/j.jacc.2010.12.011 1:CAS:528:DC%2BC3MXosFeks7s%3D
-
Assimes TL, Hólm H, Kathiresan S, et al. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. (J Am Coll Cardiol. 2010 Nov 2, 56(19), pp. 1552-63. Erratum in). J Am Coll Cardiol. 2011;57(4):520.
-
(2011)
J Am Coll Cardiol.
, vol.57
, Issue.4
, pp. 520
-
-
Assimes, T.L.1
Hólm, H.2
Kathiresan, S.3
-
24
-
-
84892434147
-
KIF6 carrier status in Asians predicts beneficial response to statins
-
Fung G, Aparicio AF, Wu A, Smith A, Wong I. KIF6 carrier status in Asians predicts beneficial response to statins. Circulation. 2012;125:AP327.
-
(2012)
Circulation.
, vol.125
, pp. 327
-
-
Fung, G.1
Aparicio, A.F.2
Wu, A.3
Smith, A.4
Wong, I.5
-
25
-
-
80052762422
-
Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention
-
21493817 10.1161/CIRCGENETICS.110.959353 1:CAS:528:DC%2BC3MXps1Onsrk%3D
-
Ridker PM, MacFadyen JG, Glynn RJ, et al. Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention. Circ Cardiovasc Genet. 2011;4(3):312-7.
-
(2011)
Circ Cardiovasc Genet.
, vol.4
, Issue.3
, pp. 312-317
-
-
Ridker, P.M.1
MacFadyen, J.G.2
Glynn, R.J.3
-
26
-
-
79955875125
-
No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the Heart Protection Study
-
21458191 10.1016/j.jacc.2011.02.015 1:CAS:528:DC%2BC3MXnslKms7o%3D
-
Hopewell JC, Parish S, Clarke R, et al. No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the Heart Protection Study. J Am Coll Cardiol. 2011;57(20):2000-7.
-
(2011)
J Am Coll Cardiol.
, vol.57
, Issue.20
, pp. 2000-2007
-
-
Hopewell, J.C.1
Parish, S.2
Clarke, R.3
-
27
-
-
35248901000
-
Long-term follow-up of the West of Scotland coronary prevention study
-
17928595 10.1056/NEJMoa065994 1:CAS:528:DC%2BD2sXhtFKmur%2FK
-
Ford I, Murray H, Packard CJ, et al. Long-term follow-up of the West of Scotland coronary prevention study. N Engl J Med. 2007;357(15):1477-86.
-
(2007)
N Engl J Med.
, vol.357
, Issue.15
, pp. 1477-1486
-
-
Ford, I.1
Murray, H.2
Packard, C.J.3
-
28
-
-
83755186157
-
A common KIF6 polymorphism increases vulnerability to low-density lipoprotein cholesterol: Two meta-analyses and a meta-regression analysis
-
22216121 10.1371/journal.pone.0028834 1:CAS:528:DC%2BC38XksFCmtw%3D%3D
-
Ference BA, Yoo W, Flack JM, Clarke M. A common KIF6 polymorphism increases vulnerability to low-density lipoprotein cholesterol: two meta-analyses and a meta-regression analysis. PLoS ONE. 2011;6(12):e28834.
-
(2011)
PLoS ONE.
, vol.6
, Issue.12
, pp. 28834
-
-
Ference, B.A.1
Yoo, W.2
Flack, J.M.3
Clarke, M.4
-
29
-
-
77955467684
-
KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: Results from the PROSPER study
-
20215968 10.1097/HJR.0b013e328336a0dd
-
Iakoubova OA, Robertson M, Tong CH, et al. KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study. Eur J Cardiovasc Prev Rehabil. 2010;17(4):455-61.
-
(2010)
Eur J Cardiovasc Prev Rehabil.
, vol.17
, Issue.4
, pp. 455-461
-
-
Iakoubova, O.A.1
Robertson, M.2
Tong, C.H.3
|